Phase 2 Basket Trial Results Claim Success in BRaf V600-Mutated Cancers
August 20th 2015Conducted by researchers at the Memorial Sloan Kettering Cancer Center, phase 2 results from a basket trial evaluated the efficacy of vemurafenib on nonmelanoma BRaf V600-mutated cancers in 122 patients across 23 global centers.
Read More
CHAARTED Study: Conceptual Shift in Early Prostate Cancer Treatment
August 14th 2015Analysis of results from the CHAARTED trial, published in the New England Journal of Medicine, has found that 6 cycles of chemotherapy (docetaxel) before androgen-deprivation therapy early in the treatment of metastatic prostate cancer significantly improved overall survival than treatment with ADT alone.
Read More
JAMA Oncology Study Validates Patient-Reported Outcomes
August 14th 2015A multicollaborative study conducted for the National Cancer Institute has resulted in a tool called the Common Terminology Criteria for Adverse Events (PRO-CTCAE). PRO-CTCAE can help integrate the patient perspective into adverse event reporting.
Read More
No Solution in Sight Yet With the Federal 340B Program, Say Stakeholders
August 13th 2015A panel of healthcare experts invited by The American Journal of Managed Care participated in the Oncology Stakeholders Summit, Spring 2015 Peer Exchange, to discuss 340B and other issues in oncology care.
Read More
Choosing Well in Older Breast Cancer Patients: Retrospective Study Provides Leads
August 13th 2015A study published in the Journal of the American Geriatrics Society found that older women with breast cancer have a poor response to chemotherapy, while older patients with advanced colon cancer (both men and women) did well.
Read More
Need for Consistency in Radiation Treatment Costs Among Medicare Enrollees
August 12th 2015Research published in the Journal of Oncology Practice found that factors unrelated to the individual patient accounted for the majority of variation in the cost of radiation therapy for breast, prostate, and lung cancer patients.
Read More
Urban Emergency Departments Play a Critical Role in Identifying Undiagnosed HCV Patients
August 7th 2015An emergency department screening and testing program based on birth cohort screening and injectable drug use found a high prevalence of the hepatitis C virus antibody among the cohorts tested, and identified several barriers to clinical implementation of the process.
Read More